SCHEMBL1897508

SCHEMBL1897508

C=C(CO)C(=O)OC(C)(OCC)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089850 0.81 MGAM (0.30)
SCHEMBL7089854 0.81 ALOX15 (0.33)
SCHEMBL10834615 0.80 THRB (0.42)
SCHEMBL351999 0.77 TDP1 (0.34)
SCHEMBL21439784 0.76 ALDH1A1 (0.32)
SCHEMBL5450323 0.72 ALDH1A1 (0.40)
SCHEMBL28603621 0.71 THRB (0.42)
SCHEMBL22325465 0.71 L3MBTL1 (0.31)
SCHEMBL27773746 0.70 TSHR (0.45)
SCHEMBL10872187 0.70 THRB (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023076629-A1 HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLS SLINGSHOT BIOSCIENCES, INC. (US) 2023-05-04 WO claimed
EP-2498867-A1 GALVANIC SKIN TREATMENT DEVICE Johnson & Johnson Consumer Companies, Inc. (US) 2012-09-19 EP disclosed
EP-2349459-A1 TREATMENT OF SWEATING AND HYPERHIDROSIS Johnson & Johnson Consumer Companies, Inc. (US) 2011-08-03 EP disclosed
WO-2011059915-A1 GALVANIC SKIN TREATMENT DEVICE JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2011-05-19 WO disclosed
WO-2010027792-A1 TREATMENT OF SWEATING AND HYPERHIDROSIS JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2010-03-11 WO disclosed